EWP
ARKG icon

Engrave Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Engrave Wealth Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,174
Closed -$72K – 417
2019
Q4 		$72K Buy
+2,174
New +$69.1K 0.07% 104

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
CPA
Capital Planning Advisors Roseville, California $692M AUM 21.81% 1-Year Est. Return

Engrave Wealth Partners's ARKG Position: Q1 2020 in Review

Engrave Wealth Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2020, closing a stake of 2,174 shares — an estimated $72K sold.

Engrave Wealth Partners first reported a position in ARKG in Q4 2019 and held it in 1 quarter. The position peaked at $72K in Q4 2019. 106 funds tracked by Wall St. Rank hold ARKG as of Q1 2020.

  • Engrave Wealth Partners reported no remaining ARK Genomic Revolution ETF position as of Q1 2020 after selling out during the quarter.
  • Engrave Wealth Partners sold 2,174 ARK Genomic Revolution ETF shares in Q1 2020, an estimated $72K.
  • Engrave Wealth Partners first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 1 quarter.
  • Engrave Wealth Partners's ARK Genomic Revolution ETF position peaked at $72K in Q4 2019.
  • 106 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2020.

Based on Engrave Wealth Partners's 13F filing for Q1 2020, filed 20 Apr 2020.